VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NATR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NATRNature's Sunshine Products, Inc.
$21.75$382M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

NATR logoNature's Sunshine Products, Inc.(NATR)Earnings, Financials & Key Ratios

NATR•NASDAQ
$21.67
20.4× P/E·Price updated Jul 6, 2026
SectorConsumer DefensiveIndustryPackaged FoodsSub-IndustryNutrition and functional foods
AboutNature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.Show more
  • Revenue$480M+5.7%
  • EBITDA$39M+12.5%
  • Net Income$20M+153.7%
  • EPS (Diluted)1.06+165.0%
  • Gross Margin72.42%+1.3%
  • EBITDA Margin8.04%+6.4%
  • Operating Margin5.15%+16.5%
  • Net Margin4.07%+140.0%
  • ROE12.1%+152.1%

NATR Price & Volume

Nature's Sunshine Products, Inc. (NATR) stock price & volume — 10-year historical chart

Loading chart...

Volatile Revenue Growth Masks Structural Margin Stability

Investment Thesis • Updated 2026Q1

VerdictNeutral
Growth:Mixed
Profitability:Strained
Financial:Healthy
Cash Flow:Mixed
Primary Risk:Consultant network churn volatility

Key Thesis Takeaways

  • Nature's Sunshine maintains a resilient balance sheet with a low 0.13 debt-to-equity ratio, yet faces persistent challenges in scaling operating margins, which fluctuated between 3.7% and 7.8% over the last ten quarters.
  • While the company benefits from a consistent 72% gross margin profile, its reliance on a high-touch consultant network introduces significant revenue volatility and earnings unpredictability.
  • Investors should monitor the company's ability to convert operational gains into sustainable free cash flow, as recent periods have seen erratic cash conversion cycles and significant working capital outflows.

Verdict Logic

while the company maintains a healthy balance sheet with $87.6 million in cash, the inconsistent free cash flow margins, which swung between -3.5% and 13.1%, suggest significant execution risk in the direct-selling model.

NATR Growth Metrics

Nature's Sunshine Products, Inc. (NATR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years3.99%
5 Years4.5%
3 Years4.4%
TTM7.26%

Profit CAGR

10 Years2.89%
5 Years-1.76%
3 Years-
TTM96.52%

EPS CAGR

10 Years3.25%
5 Years-0.19%
3 Years-
TTM106.38%

Return on Capital

10 Years10.12%
5 Years13.01%
3 Years12.16%
Last Year13.83%

NATR Recent Earnings

Nature's Sunshine Products, Inc. (NATR) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 6/12 qtrs (50%)
Q2 2026Latest
May 7, 2026
Metric
Actual
Est
EPS
$0.30+46.3%
$0.20
Rev
$123M+0.6%
$122M
Q2 2026
Mar 10, 2026
Metric
Actual
Est
EPS
$0.30+62.2%
$0.18
Rev
$124M+1.9%
$122M
Q4 2025
Nov 6, 2025
Metric
Actual
Est
EPS
$0.36+89.5%
$0.19
Rev
$128M+5.5%
$122M
Q3 2025
Jul 31, 2025
Metric
Actual
Est
EPS
$0.35+94.4%
$0.18
Rev
$115M-3.9%
$119M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 7, 2026
$0.30vs $0.20+46.3%
$123Mvs $122M+0.6%
Q2 2026Mar 10, 2026
$0.30vs $0.18+62.2%
$124Mvs $122M+1.9%
Q4 2025Nov 6, 2025
$0.36vs $0.19+89.5%
$128Mvs $122M+5.5%
Q3 2025Jul 31, 2025
$0.35vs $0.18+94.4%
$115Mvs $119M-3.9%
Based on last 12 quarters of dataView full earnings history →

Peers Comparison

Key metrics vs top competitors for Nature's Sunshine Products, Inc. (NATR)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
NATR logoNATRNature's Sunshine Products, Inc.Current
$21.67$381.06M20.445.67%4.07%12.1%—
USNA logoUSNAUSANA Health Sciences, Inc.
$21.78$402.12M37.558.28%0.96%1.51%—
NUS logoNUSNu Skin Enterprises, Inc.
$5.04$244.69M1.58-14.26%3.78%6.84%—
NHTC logoNHTCNatural Health Trends Corp.
$1.88$20.98M-24.51-7.42%-3.03%-4.88%—
MTEX logoMTEXMannatech, Incorporated
$5.04$9.73M-0.63-8.34%-11.97%-2383.34%—
HLF logoHLFHerbalife Nutrition Ltd.
$12.87$1.33B5.850.89%4.67%——

Compare NATR vs Peers

Nature's Sunshine Products, Inc. (NATR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs USNA

Most directly comparable listed peer for NATR.

Scale Benchmark

vs AMZN

Larger-name benchmark to compare NATR against a more recognizable public peer.

Peer Set

Compare Top 5

vs USNA, NUS, NHTC, MTEX

NATR SEC Filings & Documents

Nature's Sunshine Products, Inc. (NATR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 11, 2026·SEC

Material company update

May 7, 2026·SEC

Material company update

Mar 10, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 10, 2026·SEC

FY 2025

Mar 11, 2025·SEC

FY 2024

Mar 12, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 7, 2026·SEC

FY 2025

Nov 6, 2025·SEC

FY 2025

Jul 31, 2025·SEC

Get notified when NATR posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

NATR Frequently Asked Questions

Nature's Sunshine Products, Inc. (NATR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Nature's Sunshine Products, Inc.'s revenue?

Nature's Sunshine Products, Inc. (NATR) reported $489.8M in revenue for fiscal year 2025. This represents a 97% increase from $249.0M in 1996.

How fast is Nature's Sunshine Products, Inc. growing?

Nature's Sunshine Products, Inc. (NATR) grew revenue by 5.7% over the past year. This is steady growth.

Is NATR profitable?

Yes, Nature's Sunshine Products, Inc. (NATR) is profitable, generating $19.9M in net income for fiscal year 2025 (4.1% net margin).

Dividend & Returns
What is NATR's return on equity?

Nature's Sunshine Products, Inc. (NATR) has a return on equity (ROE) of 12.1%. This is reasonable for most industries.

What is Nature's Sunshine Products, Inc.'s free cash flow?

Nature's Sunshine Products, Inc. (NATR) generated $23.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in NATR back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →